Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia
Condition(s):LeukemiaLast Updated:May 18, 2016Completed
Hide Studies Not Open or Pending
Condition(s):LeukemiaLast Updated:May 18, 2016Completed
Condition(s):Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid LeukemiaLast Updated:February 6, 2023Completed
Condition(s):Postpartum WomenLast Updated:September 2, 2015Unknown status
Condition(s):ErythemaLast Updated:March 15, 2024Withdrawn
Condition(s):KetamineLast Updated:July 30, 2020Completed
Condition(s):Head and Neck CancerLast Updated:April 7, 2020Completed
Condition(s):Fallopian Tube Adenocarcinoma; Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube Mucinous Adenocarcinoma; Fallopian Tube Serous Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fallopian Tube Undifferentiated Carcinoma; Malignant Ovarian Brenner Tumor; Ovarian Adenocarcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mucinous Adenocarcinoma; Ovarian Seromucinous Carcinoma; Ovarian Serous Adenocarcinoma; Ovarian Transitional Cell Carcinoma; Ovarian Undifferentiated Carcinoma; Primary Peritoneal Serous Adenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal CarcinomaLast Updated:March 13, 2024Terminated
Condition(s):High Risk Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid LeukemiaLast Updated:March 15, 2024Recruiting
Condition(s):Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative DiseasesLast Updated:October 5, 2018Completed
Condition(s):Drug AddictionLast Updated:October 6, 2017Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.